What is Tirzepatide?
Tirzepatide is a dual agonist targeting both the GIP and GLP-1 receptors. It is FDA-approved for type 2 diabetes and chronic weight management, and has shown strong effects on glycemic control and body weight in trials.
Also known as: GIP/GLP-1 dual agonist
Commonly researched for
Research status
FDA-approved with large-scale human clinical trials.
Important considerations
Prescription medication with known side effects. Use only under medical supervision.